NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
-18.14%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$3.46B
AUM Growth
+$3.46B
(-30%)
Cap. Flow
-$36.7B
Cap. Flow
% of AUM
-1,058.83%
Top 10 Holdings %
Top 10 Hldgs %
72.55%
Holding
60
New
2
Increased
7
Reduced
8
Closed
3
Top Buys
| 1 |
Arcellx
ACLX
|
$72.2M |
| 2 |
Global E Online
GLBE
|
$13.3M |
| 3 |
Aurinia Pharmaceuticals
AUPH
|
$11.1M |
| 4 |
Geron
GERN
|
$3.89M |
| 5 |
RGLS
Regulus Therapeutics
RGLS
|
$2.38M |
Top Sells
| 1 |
Trevi Therapeutics
TRVI
|
$36.4B |
| 2 |
Robinhood
HOOD
|
$322M |
| 3 |
CSPR
Casper Sleep Inc.
CSPR
|
$41.6M |
| 4 |
Annexon
ANNX
|
$10.4M |
| 5 |
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
|
$1.97M |
Sector Composition
| 1 | Healthcare | 52.93% |
| 2 | Technology | 19.42% |
| 3 | Financials | 18.96% |
| 4 | Industrials | 5.25% |
| 5 | Communication Services | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Robinhood
HOOD
$92.4B
| $644M | 18.6% | 47,664,177 -23,804,549 | -33% | -$322M |
|
2
NeueHealth
NEUE
$59.2M
| $421M | 12.16% | 218,212,126 -2 | -0% | -$4 |
|
3
IonQ
IONQ
$12.7B
| $374M | 10.79% | 29,277,852 +48,193 | +0.2% | +$615K |
|
4
CRISPR Therapeutics
CRSP
$4.71B
| $366M | 10.56% | 1,590,002 | – | – |
|
5
Cloudflare
NET
$72.7B
| $225M | 6.49% | 1,877,510 | – | – |
|
|
BGRY
6
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $110M | 3.18% | 38,226,621 | – | – |
|
7
Monte Rosa Therapeutics
GLUE
$296M
| $108M | 3.12% | 7,703,205 | – | – |
|
|
CTIC
8
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $99.8M | 2.88% | 7,140,450 | – | – |
|
9
Mirum Pharmaceuticals
MIRM
$3.71B
| $92.2M | 2.66% | 4,187,801 | – | – |
|
10
BuzzFeed
BZFD
$72.6M
| $72.6M | 2.1% | 15,333,892 | – | – |
|
|
11
Arcellx
ACLX
$3.85B
| $72.2M | 2.09% | +6,437,764 | New | +$72.2M |
|
|
OYST
12
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $69M | 1.99% | 5,925,287 | – | – |
|
|
DM
13
DELISTED
Desktop Metal, Inc.
DM
| $68.3M | 1.97% | 14,407,594 | – | – |
|
14
Rhythm Pharmaceuticals
RYTM
$6.85B
| $56.6M | 1.63% | 4,912,306 | – | – |
|
15
NextNav
NN
$2.37B
| $55.2M | 1.59% | 8,189,156 | – | – |
|
|
16
Aurinia Pharmaceuticals
AUPH
$1.58B
| $49.1M | 1.42% | 3,969,834 +900,000 | +29% | +$11.1M |
|
|
UTRS
17
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| $40.5M | 1.17% | 10,001,937 +2,812 | +0% | +$11.4K |
|
|
ADAP
18
Adaptimmune Therapeutics
ADAP
$15.6M
| $35.2M | 1.02% | 17,082,611 | – | – |
|
19
Coursera
COUR
$1.88B
| $33.3M | 0.96% | 15,867,769 | – | – |
|
20
Nkarta
NKTX
$151M
| $33.1M | 0.95% | 2,904,974 | – | – |
|
21
Savara
SVRA
$567M
| $31.6M | 0.91% | 24,137,931 | – | – |
|
|
VRNA
22
Verona Pharma
VRNA
$9.16B
| $25.5M | 0.74% | 5,108,563 | – | – |
|
|
EAR
23
DELISTED
Eargo, Inc. Common Stock
EAR
| $23.9M | 0.69% | 4,520,670 | – | – |
|
|
24
Geron
GERN
$893M
| $22.2M | 0.64% | 16,318,681 +2,857,143 | +21% | +$3.89M |
|
|
AVEO
25
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $22.1M | 0.64% | 3,952,957 -1 | -0% | -$6 |
|